LEG CEO Karl Glassman Buys Company Shares
On June 12, 2026, LEG CEO Karl Glassman bought 274 shares at $9.01 each.
Key Points
- On June 12, 2026, LEG President and CEO Karl Glassman bought 274 shares at $9.01 each, totaling $2,468.74.
- Shares of LEG traded near $10.60, with peer funds like BlackRock reducing their holdings by 267,808 shares.
- Analysts such as Truist Securities and Piper Sandler have maintained hold ratings on LEG with price targets between $9 and $12.
On June 12, 2026, Karl Glassman, President and CEO of LEG, purchased 274 shares of the company at an average price of $9.01 each. This transaction amounted to a total value of $2,468.74. Glassman's purchase was not part of a pre-planned trading program.
Insider Buying and Selling at LEG
Several insiders at LEG made stock purchases on June 12, 2026. Ryan Michael Kleiboeker, EVP-Chief Strategic Planning Officer, acquired 86 shares at $9.01 each. Robert Jr. Smith, EVP, President - Specialty and FF&T, bought 310 shares at an average price of $8.6681. Other executives, including Jennifer Joy Davis, Lindsey Nicole Odaffer, and Benjamin Michael Burns, also made purchases at $9.01 per share, buying 103, 82, and 125 shares, respectively.
Other Institutional Activity in LEG
Institutional investors have been active with LEG shares. BlackRock, Inc. reduced its holdings by 267,808 shares, ending with 21,957,281 shares valued at approximately $216.9 million. Meanwhile, Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both significantly increased their positions, adding 12,207,453 and 5,774,879 shares, respectively. State Street Corp trimmed its position slightly by 30,654 shares, while Forest Avenue Capital Management LP notably boosted its holdings by 2,468,855 shares, reaching a total of 3,702,389 shares.
LEG Stock Snapshot
Shares of LEG were trading near $10.60. The stock has seen some volatility, with institutional investors adjusting their positions.
Analysts Set New Price Targets
On May 8, 2026, Truist Securities maintained its hold rating on LEG, setting a price target of $11. Piper Sandler and Goldman Sachs have also kept hold ratings, with targets ranging from $9 to $12. The consensus among analysts is a hold, with a mean target price reflecting a cautious outlook on the stock.
Bottom Line
Karl Glassman's recent purchase of LEG shares signals his confidence in the company's prospects. While some institutional investors are reducing their stakes, others are increasing their positions. Analyst ratings suggest a cautious approach, with several firms maintaining hold ratings. As always, insider transactions and analyst opinions are just pieces of the puzzle for investors tracking LEG's performance.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.